PTEN and prostate carcinoma: In the study of CNAs of prostate cancer, particular emphasis is given to PTEN deletions, often occurring in concomitance with ETS gene fusions; PTEN deletions were observed in ~23% of localized tumors and in ~70% of advanced tumors [78].